Long-Acting Cabotegravir Appears Safe in Pregnancy

(MedPage Today) -- HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir (CAB-LA; Apretude) appeared safe during pregnancy among cisgender women, according to an analysis of the HPTN 084 open-label extension trial. Composite...